Skip to main content

Table 2 The chi-square test of the relationship between risk score and clinical features in ICGC cohort

From: Eight-gene metabolic signature related with tumor-associated macrophages predicting overall survival for hepatocellular carcinoma

Clinical feature Risk Score c2 P
High risk n(%) Low risk n(%)
Age    0.899 0.343
 >65 61 (43.57%) 79 (56.43%)   
  ≤ 65 44 (50%) 44 (50%)   
Gender    0.001 0.978
 female 28 (45.91%) 33 (54.10%)   
 male 77 (46.11%) 90 (53.89%)   
Prior Malignancy    0.292 0.589
 no 93 (46.73%) 106 (53.27%)   
 yes 12 (41.38%) 17 (58.62%)   
Stage    9.806 0.002
 I-II 53 (37.32%) 87 (62.68%)   
 III-IV 52 (59.09%) 36 (40.91%)